Buda Juice IPO Overallotment Exercise Boosts Growth Capital

Buda Juice, Inc. ( (BUDA) ) just unveiled an update.

On January 21–22, 2026, Buda Juice, Inc. announced that the underwriter of its initial public offering fully exercised a 15% over-allotment option, resulting in the sale of an additional 399,999 shares at $7.50 each and bringing total IPO issuance to 3,066,666 shares and gross proceeds to about $23 million before fees. The closing of the offering and strong demand, evidenced by the full “green shoe” exercise and the start of trading on the NYSE American on January 8, 2026, provide Buda Juice with added capital, visibility, and financial flexibility to accelerate its growth strategy in the U.S. juice and beverage market, reinforcing its positioning as a profitable, differentiated fresh-juice player and potentially enhancing long-term value for shareholders and retail partners.

More about Buda Juice, Inc.

Buda Juice, Inc., listed on the NYSE American under the symbol BUDA, operates in the juice and broader beverage industry, specializing in cold-crafted UltraFresh citrus juices, lemonades, and wellness shots for grocery retailers. The company differentiates itself through an end-to-end 35°F cold chain that delivers clean-label, minimally processed products with an 8 to 12-day shelf life, merchandised in supermarket fresh produce sections as a turnkey alternative to shelf-stable beverages and in-store juicing, and is pursuing growth across branded products, new geographic markets, and a white-label platform for retail partners.

Average Trading Volume: 57,531

For detailed information about BUDA stock, go to TipRanks’ Stock Analysis page.